PSS10 - Direct medical costs following pediatric tympanostomy tube placement in the United States
Predicted, adjusted costs are significantly greater in commercially insured patients, demonstrating significantly lower reimbursement to providers who care for Medicaid pediatric patients. Health care decision makers should be aware of these findings as they develop plans to allocate resources in the pediatric setting.
Citation
Candrilli, S., Tam, IM., & Moss, JR. (2016). PSS10 - Direct medical costs following pediatric tympanostomy tube placement in the United States. Value in Health, 19(3), A123. DOI: 10.1016/j.jval.2016.03.500
